Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1962 May;25(2):143–148. doi: 10.1136/jnnp.25.2.143

A CHEMICAL INVESTIGATION OF THE DEFECTS OF MYELINATION IN PHENYLKETONURIA

L Crome 1,2, V Tymms 1,2, L I Woolf 1,2,1
PMCID: PMC495433  PMID: 13882314

Full text

PDF
143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALVORD E. C., Jr, STEVENSON L. D., VOGEL F. S., ENGLE R. L., Jr Neuropathological findings in phenyl-pyruvic oligophrenia (phenyl-ketonuria). J Neuropathol Exp Neurol. 1950 Jul;9(3):298–310. doi: 10.1097/00005072-195007000-00004. [DOI] [PubMed] [Google Scholar]
  2. ARMSTRONG M. D., TYLER F. H. Studies on phenylketonuria. I. Restricted phenylalanine intake in phenylketonuria. J Clin Invest. 1955 Apr;34(4):565–580. doi: 10.1172/JCI103105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BICKEL H., GERRARD J., HICKMANS E. M. Influence of phenylalanine intake on phenylketonuria. Lancet. 1953 Oct 17;265(6790):812–813. doi: 10.1016/s0140-6736(53)90473-5. [DOI] [PubMed] [Google Scholar]
  4. BLAINEY J. D., GULLIFORD R. Phenylalanine-restricted diets in the treatment of phenylketonuria. Arch Dis Child. 1956 Dec;31(160):452–466. doi: 10.1136/adc.31.160.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BRIMBLECOMBE F. S., STONEMAN M. E., MALIPHANT R. Dietary treatment of an infant with phenylketonuria. Lancet. 1959 Mar 21;1(7073):609–611. doi: 10.1016/s0140-6736(59)92356-6. [DOI] [PubMed] [Google Scholar]
  6. CROME L. The association of phenylketonuria with leucodystrophy. J Neurol Neurosurg Psychiatry. 1962 May;25:149–153. doi: 10.1136/jnnp.25.2.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DAVISON A. N., SANDLER M. Inhibition of 5-hydroxytryptophan decarboxylase by phenylalanine metabolites. Nature. 1958 Jan 18;181(4603):186–187. doi: 10.1038/181186b0. [DOI] [PubMed] [Google Scholar]
  8. FELLMAN J. H. Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia. Proc Soc Exp Biol Med. 1956 Dec;93(3):413–414. doi: 10.3181/00379727-93-22773. [DOI] [PubMed] [Google Scholar]
  9. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  10. JERVIS G. A. Phenylpyruvic oligophrenia (phenylketonuria). Res Publ Assoc Res Nerv Ment Dis. 1954;33:259–282. [PubMed] [Google Scholar]
  11. JOHNSON A. C., McNABB A. R., ROSSITER R. J. Chemical studies of peripheral nerve during Wallerian degeneration; lipids. Biochem J. 1949;45(4):500–508. doi: 10.1042/bj0450500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. LOW N. L., BOSMA J. F., ARMSTRONG M. D. Studies on phenylketonuria. VI. EEG studies in phenylketonuria. AMA Arch Neurol Psychiatry. 1957 Apr;77(4):359–365. doi: 10.1001/archneurpsyc.1957.02330340035003. [DOI] [PubMed] [Google Scholar]
  13. PARE C. M., SANDLER M., STACEY R. S. 5-Hydroxytryptamine deficiency in phenylketonuria. Lancet. 1957 Mar 16;272(6968):551–553. doi: 10.1016/s0140-6736(57)90920-0. [DOI] [PubMed] [Google Scholar]
  14. POSER C. M., VAN BOGAERT L. Neuro-pathologic observations in phenylketonuria. Brain. 1959 Mar;82(1):1–9. doi: 10.1093/brain/82.1.1-a. [DOI] [PubMed] [Google Scholar]
  15. RADIN N. S., LAVIN F. B., BROWN J. R. Determination of cerebrosides. J Biol Chem. 1955 Dec;217(2):789–796. [PubMed] [Google Scholar]
  16. SANDLER M., DAVIES A., RIMINGTON C. Effect of phenylacetic acid on the carcinoid syndrome. Lancet. 1959 Sep 12;2(7098):318–322. doi: 10.1016/s0140-6736(59)91359-5. [DOI] [PubMed] [Google Scholar]
  17. SVENNERHOLM L. The quantitative estimation of cerebrosides in nervous tissue. J Neurochem. 1956 May;1(1):42–53. doi: 10.1111/j.1471-4159.1956.tb12053.x. [DOI] [PubMed] [Google Scholar]
  18. TASHIAN R. E. Inhibition of brain glutamic acid decarboxylase by phenylalanine, valine, and leucine derivatives: a suggestion concerning the etiology of the neurological defect in phenylketonuria and branched-chain ketonuria. Metabolism. 1961 May;10:393–402. [PubMed] [Google Scholar]
  19. WOOLF L. I., GRIFFITHS R., MONCRIEFF A., COATES S., DILLISTONE F. The dietary treatment of phenylketonuria. Arch Dis Child. 1958 Feb;33(167):31–45. doi: 10.1136/adc.33.167.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. WOOLF L. I., GRIFFITHS R., MONCRIEFF A. Treatment of phenylketonuria with a diet low in phenylalanine. Br Med J. 1955 Jan 8;1(4905):57–64. doi: 10.1136/bmj.1.4905.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. WOOLF L. I., VULLIAMY D. G. Phenylketonuria with a study of the effect upon it of glutamic acid. Arch Dis Child. 1951 Dec;26(130):487–494. doi: 10.1136/adc.26.130.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. ZAK B. Simple rapid microtechnic for serum total cholesterol. Am J Clin Pathol. 1957 May;27(5):583–588. doi: 10.1093/ajcp/27.5_ts.583. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES